Announcements Trials
Browse Landscape

Status

Completed 4Unknown 1Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Prostatic Neoplasms 9Breast Neoplasms 7Neoplasms 5Colorectal Neoplasms 5Lung Neoplasms 4Triple Negative Breast Neoplasms 2Sarcoma 2Pancreatic Neoplasms 2Hematopoietic and Lymphatic System Neoplasm 2Hematologic Neoplasms 2Depression 2Carcinoma, Non-Small-Cell Lung 2Anxiety Disorders 2Alzheimer Disease 2Advanced Malignant Solid Neoplasm 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Tobacco Smoking 1Testicular Neoplasms 1Spondylitis, Ankylosing 1Specific Learning Disorder 1Smoking Cessation 1Smoking 1Signs and Symptoms 1Sedentary Behavior 1Rectal Neoplasms 1Psoriasis 1Pancreatic Diseases 1Pancreatic Cyst 1Pain 1

Interventions

pembrolizumab 54Nivolumab 50Ipilimumab 28Cyclophosphamide 16binimetinib 10Specimen Handling 10Magnetic Resonance Spectroscopy 10fludarabine 9Radiosurgery 9relatlimab 8encorafenib 8Opdualag 8Biopsy 8aldesleukin 7Interleukin-2 7atezolizumab 6Immunotherapy 6Blood Specimen Collection 6cemiplimab 5CTLA-4 Antigen 5Bevacizumab 5trametinib 4fludarabine phosphate 4dabrafenib 4Temozolomide 4Paclitaxel 4Immune Checkpoint Inhibitors 4spartalizumab 3Surgical Procedures, Operative 3Metformin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Melanoma × Methods × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡